Sintx Technologies, Inc. (SINT)
NASDAQ: SINT · Real-Time Price · USD
4.540
0.00 (0.00%)
At close: Sep 26, 2025, 4:00 PM EDT
4.510
-0.030 (-0.66%)
After-hours: Sep 26, 2025, 7:33 PM EDT
Company Description
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States.
The company offers solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and polyetherketoneketone.
The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
Sintx Technologies, Inc.
| Country | United States |
| Founded | 1996 |
| IPO Date | Feb 13, 2014 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 20 |
| CEO | Eric Olson |
Contact Details
Address: 1885 West 2100 South Salt Lake City, Utah 84119 United States | |
| Phone | 801 839 3500 |
| Website | sintx.com |
Stock Details
| Ticker Symbol | SINT |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001269026 |
| CUSIP Number | 829392307 |
| ISIN Number | US8293927039 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Eric K. Olson | President, Chief Executive Officer and Chairman of the Board |
| Kevin Trask | Chief Financial Officer |
| Gregg Richard Honigblum | Chief Investment Officer and Director |
| Dr. Ryan Bock Ph.D. | Chief Technology Officer |
| Kevin J. Ontiveros Esq. | Chief Legal Officer |
| Brian Hockett | Senior Vice President of Regulatory and Quality Affairs |
| Hugh Roberts | Managing Director of Business Development |
| Lisa Marie Del Re | Chief Commercial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 9, 2025 | 8-K | Current Report |
| Sep 5, 2025 | 8-K | Current Report |
| Sep 3, 2025 | SCHEDULE 13G | Filing |
| Aug 14, 2025 | 10-Q | Quarterly Report |
| Jul 31, 2025 | DEF 14A | Other definitive proxy statements |
| Jul 22, 2025 | 8-K | Current Report |
| Jul 3, 2025 | SCHEDULE 13G | Filing |
| Jun 27, 2025 | 8-K | Current Report |
| May 22, 2025 | 8-K | Current Report |
| May 15, 2025 | SCHEDULE 13G/A | Filing |